A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin As Adjuvant Therapy of Node Positive HER2 Negative Breast Cancer: The ABC Trial
Brief description of study
If you have been diagnosed with breast cancer and have completed the usual chemotherapy, surgery and/or radiation therapy for breast cancer, you may qualify for this study. The main goal of this study will evaluate whether patients taking aspirin once per day will have a lower rate of cancer recurrence.
Clinical Study Identifier: s17-00022
ClinicalTrials.gov Identifier: NCT02927249
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
